Your browser doesn't support javascript.
loading
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Fumet, Jean-David; Richard, Corentin; Ledys, Fanny; Klopfenstein, Quentin; Joubert, Philippe; Routy, Bertrand; Truntzer, Caroline; Gagné, Andréanne; Hamel, Marc-André; Guimaraes, Camila Figueiredo; Coudert, Bruno; Arnould, Laurent; Favier, Laure; Lagrange, Aurélie; Ladoire, Sylvain; Saintigny, Pierre; Ortiz-Cuaran, Sandra; Perol, Maurice; Foucher, Pascal; Hofman, Paul; Ilie, Marius; Chevrier, Sandy; Boidot, Romain; Derangere, Valentin; Ghiringhelli, François.
  • Fumet JD; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Richard C; Research Platform in Biological Oncology, Dijon, France.
  • Ledys F; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Klopfenstein Q; University of Burgundy-Franche Comté, Dijon, France.
  • Joubert P; Research Platform in Biological Oncology, Dijon, France.
  • Routy B; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Truntzer C; University of Burgundy-Franche Comté, Dijon, France.
  • Gagné A; Research Platform in Biological Oncology, Dijon, France.
  • Hamel MA; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Guimaraes CF; University of Burgundy-Franche Comté, Dijon, France.
  • Coudert B; Research Platform in Biological Oncology, Dijon, France.
  • Arnould L; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Favier L; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
  • Lagrange A; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
  • Ladoire S; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada.
  • Saintigny P; Research Platform in Biological Oncology, Dijon, France.
  • Ortiz-Cuaran S; GIMI Genetic and Immunology Medical Institute, Dijon, France.
  • Perol M; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
  • Foucher P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
  • Hofman P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, QC, Canada.
  • Ilie M; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Chevrier S; Department of Pathology, Center GF Leclerc, Dijon, France.
  • Boidot R; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Derangere V; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
  • Ghiringhelli F; Department of Medical Oncology, Center GF Leclerc, Dijon, France.
Br J Cancer ; 119(8): 950-960, 2018 10.
Article en En | MEDLINE | ID: mdl-30318514
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos CD8 / Carcinoma de Pulmón de Células no Pequeñas / Linfocitos T CD8-positivos / Antígeno B7-H1 / Supervivencia sin Progresión / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos CD8 / Carcinoma de Pulmón de Células no Pequeñas / Linfocitos T CD8-positivos / Antígeno B7-H1 / Supervivencia sin Progresión / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article